CASZ1
Basic information
Region (hg38): 1:10636604-10796650
Links
Phenotypes
GenCC
Source:
- congenital heart disease (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (404 variants)
- not_specified (236 variants)
- CASZ1-related_disorder (10 variants)
- Primary_dilated_cardiomyopathy (2 variants)
- Cardiomyopathy (2 variants)
- CASZ1-associated_cardiomyopathy (1 variants)
- Autism_spectrum_disorder (1 variants)
- CASZ1-related_dilated_cardiomyopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CASZ1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001079843.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 128 | 22 | 156 | ||
| missense | 1 | 333 | 32 | 10 | 376 | |
| nonsense | 1 | 2 | 4 | 7 | ||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 7 | 10 | ||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 4 | 3 | 355 | 160 | 32 |
Highest pathogenic variant AF is 0.000008893657
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CASZ1 | protein_coding | protein_coding | ENST00000377022 | 18 | 160047 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125740 | 0 | 5 | 125745 | 0.0000199 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.61 | 866 | 1.11e+3 | 0.780 | 0.0000782 | 11414 |
| Missense in Polyphen | 387 | 576.91 | 0.67082 | 5772 | ||
| Synonymous | 0.499 | 508 | 523 | 0.972 | 0.0000438 | 3571 |
| Loss of Function | 6.72 | 4 | 60.3 | 0.0663 | 0.00000293 | 718 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000617 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000268 | 0.0000264 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441). {ECO:0000269|PubMed:23639441, ECO:0000269|PubMed:27693370}.;
Recessive Scores
- pRec
- 0.275
Intolerance Scores
- loftool
- 0.00200
- rvis_EVS
- -2.42
- rvis_percentile_EVS
- 1.06
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.532
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;multicellular organism development;positive regulation of transcription, DNA-templated
- Cellular component
- nucleoplasm;cytosol;intracellular membrane-bounded organelle
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding